CCDC no.: 1813333
Only one of the two crystallographically independent molecules of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters. 
Source of material
In the mixture of 2-(4-((1,3-dioxoisoindolin-2-yl)methyl) phenyl)ethyl-4-methylbenzenesulfonate (217.8 mg, 0.5 mmol), 50 mL EtOH and KOH (112.2 mg, 2.0 mmol), 1-(4-methoxyphenyl)piperazine (105.7 mg, 0.55 mmol) was added at ambient temperature. The reaction mixture was stirred and refluxed for 4 h, until TLC indicated the end of reaction. Then, the solvent was removed under reduced pressure, and the residue was extracted with CH 2 Cl 2 (100 mL, 3 times). The combined organic layer was successively washed with water, brine, dried over anhydrous sodium sulfate, and concentrated in vacuo. The residue was purified by silica gel column chromatography using ethyl acetate/petroleum ether (1:8, v/v) as the eluent, finally the title compound (a white solid) was afforded. 
Experimental details
All H atoms were placed in geometrically idealized positions and refined using a riding model, with C-H = 0.99 (methylene), 0.95 Å (benzene), and with U iso (H) = 1.2Ueq(C) for H atoms on methylene an benzene. The hydrogens on terminal methyls were constrained with C-H = 0.98 Å and U iso (H) = 1.5Ueq(C). One of the two crystallographically independent molecules show a disorder of the C 2 H4 moiety.
Discussion
The arylpiperazine structure is an important pharmacophore that has wide pharmacological activities [3, 4] . Naftopidil is a derivative of arylpiperazine ether and a specific antagonist targeted for the adrenergic receptor [5] , which has already been regarded as one of the most commonly utilized antagonists targeted for the adrenergic receptor to treat the benign prostatic hyperplasia (BPH) in Japan [6] . The arylpiperazine derivative mentioned in this paper is a subselective antagonist for BPH [7] . The asymmetric unit contains two independent molecules. The title compound contained three benzene rings, one piperazine ring and a pyrrole ring. In molecule A, the link part between the piperazine ring and the benzene ring was refined with a disorder model. The conformations of the two crystallographically independent molecules were similiar but not the same. In molecule B, ring (C22B-C28B) and ring (C21B-C22B-C23B-C24B-N3B) are coplanar. The dihedral angles made by the planes of (C21B-C22B-C23B-C24B-N3B) and (C14B-C19B), (C21B-C22B-C23B-C24B-N3B) and (N1B-C8B-C9B-N2B-C11B-N10B), (C21B-C22B-C23B-C24B-N3B) and (C2B-C7B) are 66.81(6)°, 68.36(5)°and 75.76(5)°, respectively. In molecule B, the dihedral angles made by the planes of (C21A-C22A-C23A-C24A-N3A) and (C14A-C19A), (C21A-C22A-C23A-C24A-N3A) and (N1A-C8A-C9A-N2A-C11A-N10A), (C21A-C22A-C23A-C24A-N3A) and (C2A-C7A) are 79.63(12)°, 80.33(14)°and 67.80(5)°, respectively. The packing of the title structure shows no classical hydrogen bonds. π-π interactions were observed between ring (C22A-C28A) and ring i (C22B-C28B) with symmetry code (i) 1 − x, 2 − y, 1 − z.
